Morgan Stanley’s Vicarious Surgical RBOT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.2K | Sell |
1,760
-311
| -15% | -$2.33K | ﹤0.01% | 6778 |
|
2025
Q1 | $13.6K | Sell |
2,071
-224
| -10% | -$1.47K | ﹤0.01% | 6707 |
|
2024
Q4 | $30.2K | Buy |
2,295
+1,739
| +313% | +$22.9K | ﹤0.01% | 6448 |
|
2024
Q3 | $3.16K | Sell |
556
-47
| -8% | -$267 | ﹤0.01% | 7033 |
|
2024
Q2 | $3.54K | Sell |
603
-3,648
| -86% | -$21.4K | ﹤0.01% | 6945 |
|
2024
Q1 | $38.5K | Sell |
4,251
-15,719
| -79% | -$142K | ﹤0.01% | 6310 |
|
2023
Q4 | $220K | Buy |
19,970
+17,890
| +860% | +$197K | ﹤0.01% | 5905 |
|
2023
Q3 | $36.9K | Sell |
2,080
-3,558
| -63% | -$63K | ﹤0.01% | 6289 |
|
2023
Q2 | $310K | Buy |
5,638
+708
| +14% | +$38.9K | ﹤0.01% | 5454 |
|
2023
Q1 | $336K | Sell |
4,930
-2,502
| -34% | -$170K | ﹤0.01% | 5469 |
|
2022
Q4 | $450K | Buy |
7,432
+5,656
| +318% | +$343K | ﹤0.01% | 5300 |
|
2022
Q3 | $179K | Buy |
1,776
+1,189
| +203% | +$120K | ﹤0.01% | 5779 |
|
2022
Q2 | $52K | Sell |
587
-482
| -45% | -$42.7K | ﹤0.01% | 6593 |
|
2022
Q1 | $162K | Buy |
1,069
+519
| +94% | +$78.7K | ﹤0.01% | 6036 |
|
2021
Q4 | $175K | Sell |
550
-2,347
| -81% | -$747K | ﹤0.01% | 6137 |
|
2021
Q3 | $1.3M | Buy |
2,897
+2,753
| +1,912% | +$1.23M | ﹤0.01% | 4879 |
|
2021
Q2 | $43K | Hold |
144
| – | – | ﹤0.01% | 6730 |
|
2021
Q1 | $43K | Buy |
+144
| New | +$43K | ﹤0.01% | 6413 |
|